RxDoctor Payments Data

Colt Cansler, PA

Physician Assistant · Marion, INNPI 1043622525

Payments from drug & device makers

$2,871in general payments, 2019–2025

Across 127 payments — averaging $22.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spinal Simplicity, LLC$719
  • Pfizer$478
  • Collegium Pharmaceutical, Inc.$464
  • AbbVie$338
  • Nalu Medical, Inc.$149
  • Curonix LLC$147
  • plus $576 from 10 others

What the payments were for

  • Travel & lodging$30010%
  • Food & beverage$2,57190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,871 in reported general payments places this provider in the 85th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Medicare billing

Part B allowed, 2024
$172,889
Medicare patients
375
Services billed
3,534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate157$108,777
RelistorMethylnaltrexone Bromide39$95,471
OxycontinOxycodone Hcl90$79,954
NucyntaTapentadol Hcl60$73,252
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,648$67,421
BelbucaBuprenorphine Hcl55$38,035
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,254$34,770
MovantikNaloxegol Oxalate63$28,698
Nurtec OdtRimegepant Sulfate19$20,573
UbrelvyUbrogepant13$19,550
Nucynta ErTapentadol Hcl12$18,677
Oxycodone Hcl718$18,100
Buprenorphine70$17,594
ZtlidoLidocaine19$17,220
LyricaPregabalin18$15,951

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta, Belbuca, Nucynta Er$464$238,741284 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$17$95,47139 claims
PfizerNurtec Odt, Lyrica$478$36,52337 claims
AbbVieUbrelvy, Linzess$338$29,37131 claims
Scilex Pharmaceuticals Inc.Ztlido$57$17,22019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Marion

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →